Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance

Author： Barnes D.M.   Millis R.R.   Beex L.V.A.M.   Thorpe S.M.   Leake R.E.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.11, 1998-10, pp. : 1677-1682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Canine Inflammatory Mammary Carcinoma: Histopathology, Immunohistochemistry and Clinical Implications of 21 Cases

By Peña L.   Dolores Perez-Alenza M.   Rodriguez-Bertos A.   Nieto A.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 2, 2003-03 ,pp. : 141-148

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Significance of Progesterone Receptor Immunohistochemistry in Endometrial Carcinoma

By Fukuda K.   Mori M.   Uchiyama M.   Iwai K.   Iwasaka T.   Sugimori H.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 220-225

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Progesterone Receptor Immunohistochemistry for Lymph Node Metastases in Endometrial Carcinoma

By Iwai K.   Fukuda K.   Hachisuga T.   Mori M.   Uchiyama M.   Iwasaka T.   Sugimori H.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 351-359

Elsevier

Access to resources Recommend Favorite

The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells

By              

International Journal of Oncology, Vol. 41, Iss. 6, 2012-01 ,pp. : 2285-2295

Spandidos Publications

Access to resources Recommend Favorite

Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor α

By            

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 106-114

Spandidos Publications

Access to resources Recommend Favorite